AWM Investment Company »

Immunovant shares owned by AWM Investment Company

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by AWM Investment Company from 13F filings

Historical chart of AWM Investment Company investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by AWM Investment Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by AWM Investment Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.9M 70k 42.13
2023-09-30 $1.9M 50k 38.39

More positions owned by AWM Investment Company

Destination XL Group common (DXLG)
Aspen Aerogels common (ASPN)
Aehr Test Systems common (AEHR)
Impinj common (PI)
ADMA Biologics common (ADMA)
American Superconductor Corpor common (AMSC)
Infusystem Holdings common (INFU)
Everspin Technology common (MRAM)
Repligen Corporation common (RGEN)
Kopin Corporation common (KOPN)
Leonardo DRS common (DRS)
Arbe Robotics common (ARBE)
Ooma common (OOMA)
Universal Technical Institute common (UTI)
Aerovironment common (AVAV)

View all positions for AWM Investment Company

Top funds holding Immunovant

Vanguard Group
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Alpine Partners VI
Logos Global Management
Cormorant Asset Management
Citadel Advisors
Commodore Capital
Boxer Capital
Redmile Group
Fred Alger Management
Millennium Management
Dimensional Fund Advisors
Ikarian Capital

View all funds holding Immunovant